NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
Crossref DOI link: https://doi.org/10.1186/s12967-015-0397-0
Published Print: 2015
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van den Heuvel, Michel M
Verheij, Marcel
Boshuizen, Rogier
Belderbos, José
Dingemans, Anne-Marie C
De Ruysscher, Dirk
Laurent, Julien
Tighe, Robert
Haanen, John
Quaratino, Sonia
License valid from 2015-01-01